New Post Public Reply Private Reply Replies (0) Message Board ← Newer Older → News Desk 2022 Mar 29, 2019 at 12:00 PM 64 Intellipharmaceutics International Inc. (IPCIF: OTCQB) | U.S. FDA Acknowledges Receipt of Intellipharmaceutics' Resubmission of Oxycodone ER New Drug Application, Deems it a Complete Response, and Designates August 28, 2019 as Goal Date for Review Newer Older
